Is FIV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FIV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: FIV (CHF189.22) is trading above our estimate of fair value (CHF182.65)
Significantly Below Fair Value: FIV is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FIV?
Key metric: As FIV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for FIV. This is calculated by dividing FIV's market cap by their current
earnings.
What is FIV's PE Ratio?
PE Ratio
41.2x
Earnings
US$3.06b
Market Cap
US$126.05b
FIV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: FIV is expensive based on its Price-To-Earnings Ratio (41.2x) compared to the European Diversified Financial industry average (10.7x).
Price to Earnings Ratio vs Fair Ratio
What is FIV's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
FIV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
41.2x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate FIV's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst FIV forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
CHF 199.17
0%
9.8%
CHF 248.60
CHF 143.08
n/a
34
Nov ’25
n/a
CHF 189.66
0%
9.1%
CHF 212.43
CHF 139.30
n/a
33
Oct ’25
CHF 149.99
CHF 155.43
+3.6%
6.3%
CHF 171.78
CHF 131.16
n/a
33
Sep ’25
CHF 143.81
CHF 150.74
+4.8%
7.9%
CHF 168.47
CHF 109.51
n/a
33
Aug ’25
n/a
CHF 157.24
0%
7.7%
CHF 176.79
CHF 114.91
n/a
32
Jul ’25
n/a
CHF 154.38
0%
7.6%
CHF 178.88
CHF 116.27
n/a
34
Jun ’25
n/a
CHF 157.11
0%
8.5%
CHF 182.93
CHF 118.91
n/a
33
May ’25
n/a
CHF 154.89
0%
8.5%
CHF 182.77
CHF 118.80
n/a
34
Apr ’25
CHF 139.65
CHF 146.44
+4.9%
8.1%
CHF 167.34
CHF 117.59
n/a
34
Mar ’25
n/a
CHF 140.00
0%
7.7%
CHF 163.01
CHF 114.55
n/a
34
Feb ’25
n/a
CHF 131.25
0%
9.2%
CHF 159.72
CHF 111.11
n/a
34
Jan ’25
n/a
CHF 124.71
0%
10.5%
CHF 158.27
CHF 102.66
n/a
32
Dec ’24
n/a
CHF 124.81
0%
8.3%
CHF 154.07
CHF 105.65
n/a
31
Nov ’24
n/a
CHF 127.51
0%
8.9%
CHF 158.87
CHF 108.94
n/a
32
Oct ’24
n/a
CHF 127.24
0%
8.4%
CHF 152.62
CHF 99.65
CHF 149.99
30
Sep ’24
n/a
CHF 124.62
0%
8.1%
CHF 149.23
CHF 97.44
CHF 143.81
31
Aug ’24
CHF 108.56
CHF 123.36
+13.6%
8.5%
CHF 148.79
CHF 97.15
n/a
32
Jul ’24
n/a
CHF 120.48
0%
7.6%
CHF 143.18
CHF 99.33
n/a
32
Jun ’24
n/a
CHF 118.70
0%
8.3%
CHF 142.40
CHF 97.90
n/a
31
May ’24
n/a
CHF 118.82
0%
8.0%
CHF 138.54
CHF 98.32
n/a
31
Apr ’24
n/a
CHF 116.35
0%
9.7%
CHF 140.76
CHF 91.40
CHF 139.65
31
Mar ’24
n/a
CHF 118.89
0%
10.3%
CHF 144.14
CHF 93.60
n/a
32
Feb ’24
n/a
CHF 109.45
0%
11.3%
CHF 140.02
CHF 87.51
n/a
32
Jan ’24
n/a
CHF 112.96
0%
10.3%
CHF 142.31
CHF 88.94
n/a
32
Dec ’23
n/a
CHF 116.77
0%
10.6%
CHF 146.72
CHF 91.70
n/a
32
Nov ’23
n/a
CHF 120.49
0%
10.6%
CHF 151.31
CHF 94.57
n/a
32
Analyst Forecast: Target price is less than 20% higher than the current share price.